2024-08-22 |
EXDO6650018841 |
RISING PHARMA HOLDINGS INC |
7783.0 kg |
300490
|
FUROSEMIDE TABLETS HTS: 300490 BUPROPION XL 300MG TABLETS HTS: 300490 HYDROXYZINE HYDROCHLORIDE TABLETS USP HTS: 300490 |
2024-07-06 |
EXDO6650018472 |
BIOCON PHARMA INC |
8113.0 kg |
300490
|
ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE HTS: 300490 |
2023-10-02 |
EXDO6650016806 |
BIOCON PHARMA INC |
7675.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-08-28 |
EXDO6650016704 |
BIOCON PHARMA INC |
7455.0 kg |
300490
|
ATORVASTATON CALCIUM TABLETS HTS: 300490 |
2023-08-13 |
EXDO6650016613 |
BIOCON PHARMA INC |
11492.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-08-02 |
EXDO6650016511 |
BIOCON PHARMA INC |
7942.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-07-25 |
EXDO6650016488 |
BIOCON PHARMA INC |
7572.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-07-14 |
EXDO6650016371 |
BIOCON PHARMA INC |
8248.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-07-14 |
EXDO6650016087 |
BIOCON PHARMA INC |
8589.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-06-20 |
EXDO6650016310 |
BIOCON PHARMA INC |
7843.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-05-13 |
EXDO6650016083 |
BIOCON PHARMA INC |
7562.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-05-13 |
EXDO6650016086 |
BIOCON PHARMA INC |
4291.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-04-24 |
EXDO6650016032 |
BIOCON PHARMA INC |
9051.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-04-18 |
EXDO6650016082 |
BIOCON PHARMA INC |
8343.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-04-18 |
EXDO6650016084 |
BIOCON PHARMA INC |
9333.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-04-18 |
EXDO6650016085 |
BIOCON PHARMA INC |
11572.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-04-11 |
EXDO6650015960 |
BIOCON PHARMA INC |
7831.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 30049099 |
2023-04-11 |
EXDO6650015961 |
BIOCON PHARMA INC |
9032.0 kg |
300490
|
IATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-04-07 |
EXDO6650015998 |
BIOCON PHARMA INC |
6699.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-04-07 |
EXDO6650015918 |
BIOCON PHARMA INC |
7859.0 kg |
300490
|
ATORVASTATIN CALCIUM HTS: 300490 |
2023-03-23 |
EXDO6650015907 |
BIOCON PHARMA INC |
8014.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-03-14 |
EXDO6650015889 |
BIOCON PHARMA INC |
8404.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-03-06 |
EXDO6650015836 |
BIOCON PHARMA INC |
7988.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-03-02 |
EXDO6650015790 |
BIOCON PHARMA INC |
8232.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-03-02 |
EXDO6650015791 |
BIOCON PHARMA INC |
7637.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-02-23 |
EXDO6650015748 |
BIOCON PHARMA INC |
7646.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2023-02-23 |
EXDO6650015747 |
BIOCON PHARMA INC |
8233.0 kg |
300490
|
ATORVASTATIIN CALCIUM TABLETS HTS: 300490 |
2023-02-15 |
EXDO6650015638 |
BIOCON PHARMA INC |
9022.0 kg |
300490
|
ATORVASTATIN CALSIUM TABLETS HTS: 300490 |
2023-02-15 |
EXDO6650015723 |
BIOCON PHARMA INC |
9042.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 300490 |
2023-02-01 |
EXDO6650015626 |
BIOCON PHARMA INC |
7595.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-27 |
EXDO6650015604 |
BIOCON PHARMA INC |
8939.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-17 |
EXDO6650015549 |
BIOCON PHARMA INC |
8438.0 kg |
300490
|
IATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-17 |
EXDO6650015548 |
BIOCON PHARMA INC |
8885.0 kg |
300490
|
IATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-17 |
EXDO6650015547 |
BIOCON PHARMA INC |
8739.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-08 |
EXDO6650015422 |
BIOCON PHARMA INC |
8648.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-07 |
EXDO6650015453 |
BIOCON PHARMA INC |
8412.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2023-01-07 |
EXDO6650015377 |
BIOCON PHARMA INC |
8563.0 kg |
300490
|
ATORVASTATIN CALSIUM TABLETS HTS: 30049099 |
2023-01-07 |
EXDO6650015523 |
PRIORITY HEALTHCARE DISTRIBUTION |
5882.0 kg |
300490
|
ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE HTS: 300490 |
2022-12-26 |
EXDO6650015378 |
BIOCON PHARMA INC |
8641.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2022-12-14 |
EXDO6650015366 |
BIOCON PHARMA INC |
7519.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2022-12-07 |
EXDO6650015309 |
BIOCON PHARMA INC |
7885.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP HTS: 300490 |
2022-12-01 |
EXDO6650015288 |
BIOCON PHARMA INC |
9223.0 kg |
300490
|
ASTORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2022-12-01 |
EXDO6650015098 |
BIOCON PHARMA INC |
8611.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2022-11-11 |
EXDO6650015147 |
BIOCON PHARMA INC |
7726.0 kg |
300490
|
ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE HTS: 300490 |
2022-10-21 |
EXDO6650015108 |
BIOCON PHARMA INC |
8321.0 kg |
300490
|
ATORVASTATIN CALCIUIM TABLETS HTS: 30049099 |
2022-10-11 |
EXDO6650015107 |
BIOCON PHARMA INC |
8595.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2022-10-08 |
EXDO6650015043 |
BIOCON PHARMA INC |
8156.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |
2022-10-08 |
EXDO6650014989 |
BIOCON PHARMA INC |
6563.0 kg |
300490
|
ESOMEPRAZOLE MAGNESIUM CAPSULES HTS: 30049099 |
2022-10-08 |
EXDO6650015042 |
BIOCON PHARMA INC |
8548.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS USP 80MG HTS: 30049099 |
2022-10-08 |
EXDO6650014988 |
BIOCON PHARMA INC |
8414.0 kg |
300490
|
ATORVASTATIN CALCIUM TABLETS HTS: 30049099 |